These hub genes were associated with progression of obesity associated type 2 diabetes mellitus and first five (CEBPD, TP73, ESR2, TAB1 and MAP 3K5) of them might be linked with targeted therapy. This evidence concerns the gene TAB1 and obesity due to melanocortin 4 receptor deficiency.